DexCom Says Diabetes Tech Issue Isn't Investor Fraud
Medical device maker DexCom Inc. has urged a New York federal judge to toss a proposed investor class action over the reliability of the company's glucose monitoring device, arguing the suit...To view the full article, register now.
Already a subscriber? Click here to view full article